• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$12.15 $0.76 (6.67%)

REAL-TIME: Last trade at

MAP Pharmaceuticals

NASDAQ:MAPP

Jump to this page for:

Related Resources

Pepco Lowered to Neutral - Analyst Blog

5/18/2012 by Nasdaq

US STOCK FUTURES: HOT STOCKS TO WATCH

4/13/2012 by Smart Money

US STOCK FUTURES: HOT STOCKS TO WATCH

4/13/2012 by Smart Money

Map Pharmaceuticals Plans FDA Meeting To Discuss Manufacturing Issues

4/12/2012 by Smart Money

FDA Delay Points to Blockbuster Approval

4/10/2012 by DailyFinance

Charting a Course to Profit

4/4/2012 by DailyFinance

3 Earnings Reports That Caught My Attention Last Week

4/2/2012 by DailyFinance

Investors Faint From FDA Rejection

3/29/2012 by DailyFinance

3 Stocks to Get on Your Watchlist

3/28/2012 by DailyFinance

MAP Confident In Levadex, Plans Swift Response To FDA

3/27/2012 by Smart Money

Map Pharmaceuticals Drops on Migraine Drug Rejection

3/27/2012 by Minyanville

Call It an "Almost Approval"

3/27/2012 by DailyFinance

Betting on the FDA: Another Round of Approval Decisions Coming for Major Drug Companies

3/9/2012 by Minyanville

Investing Ideas: The Biggest 8-K Filings Over the Last 24 Hours

11/21/2011 by Nasdaq

Top 10 Undervalued Stocks With Large Cash Cushions

11/18/2011 by DailyFinance

Monday's High-Volume Gainers With Conservative Accounting Practices

5/10/2011 by Seeking Alpha

UPDATE: Allergan 1Q Earnings Sink On Charges; Outlook Raised

5/4/2011 by Smart Money

2nd UPDATE: Allergan 1Q Earnings Sink On Charges; Outlook Raised

5/4/2011 by Smart Money

George Soros's (Extremely Successful) Long-Term Holdings

4/5/2011 by Seeking Alpha

George Soros' (Extremely Successful) Long Term Holdings

4/5/2011 by Seeking Alpha

Contrarian Ideas: 6 Beaten Up Stocks With Rising Put Volume

2/24/2011 by Seeking Alpha

Top 24 Small Cap Stocks Being Chased by Smart Money

2/16/2011 by Seeking Alpha

Allergan CEO: Would Consider Expanded Agreement On Levadex

2/2/2011 by Smart Money

UPDATE: Allergan 4Q Profit Up 19%; EPS Outlooks Below Street

2/2/2011 by Smart Money

UPDATE: Allergan To Help Sell Map Pharma's Migraine Treatment

1/31/2011 by Smart Money

CORRECT:UPDATE: Allergan To Help Sell Map Pharma's Migraine Treatment

1/31/2011 by Smart Money

Momentum Ideas: 15 Undervalued Stocks Approaching An Inflection Point

11/22/2010 by Nasdaq

Wednesday's High Volume Gainers With Bullish Options Sentiment

11/11/2010 by Seeking Alpha

Map Pharmaceuticals Sees Positive Study Results For Migraine Drug Levadex

6/23/2010 by Smart Money

UPDATE 1-MAP says FDA waives second trial for migraine drug

1/11/2010 by Reuters